Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
M.D. Anderson Cancer Center
With
Primary Objective: To determine the rate of undetectable MRD following treatment with glofitamab in patients with LBCL who were MRD positive at the end of standard first line treatment Secondary Objective: To determine progression-free survival (PFS), overall survival (OS), and evaluate safety of glofitamab as treatment for patients with LBCL who are MRD positive at end of standard first line treatment Exploratory Objective: To determine the biomarkers of response and mechanisms of resistance to glofitamab in LBCL To determine the kinetics of T-cell activation and exhaustion in patients treated with gofitamab to eliminate MRD
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted